JPRN-C000000112未知未知
Phase II study of carboplatin-gemcitabine combination chemotherapy in elderly patients with advanced non–small cell lung cancer - Phase II study of carboplatin-gemcitabine combination chemotherapy in elderly patients with advanced non–small cell lung cancer
Kumamoto University School of Medicine0 个研究点目标入组 55 人开始时间: 2005年9月4日最近更新:
试验速览
- 阶段
- 未知
- 发起方
- 入组人数
- 55
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 70years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Individuals with active infection, severe heart disease, active concomitant malignancy, or pleural or pericardial effusion requiring drainage were excluded.
研究者
相似试验
已完成
不适用
A phase II trial of gemcitabine plus carboplatin in advanced transitional cell carcinoma of the urotheliumCancerISRCTN88259320School of Medicine, Zhejiang University (China)39
尚未招募
不适用
Phase I study of gemcitabine and carboplatin plus sorafenib in patients with advanced solid tumorsadvanced solid tumors10027655CancerNL-OMON31053Antoni van Leeuwenhoek Ziekenhuis28
已完成
不适用
A phase II study combining gemcitabine and carboplatin in patients with platinum-resistant ovarian cancerpatients with platinum-resistant ovarian cancerJPRN-UMIN000019225Osaka medical coledge30
已完成
不适用
Randomized phase II study of carboplatin / gemcitabine versus vinorelbine / gemcitabine in patients with advanced non-small cell lung cancerStage IIIb/IV NSCLCJPRN-C000000110West Japan Oncology Group120
进行中（未招募）
2 期
GHG-GCDrelapsed or refractory non-Hodgkin's lymphomaJPRN-jRCT1041230085Tsurumi Hisashi20